Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Alaina Burns, a graduate student at the University of Arkansas for Medical Sciences, investigates the development of novel therapeutic compounds. Her recent publication focuses on the discovery of DA-143, a DNA-PKcs inhibitor designed with enhanced solubility compared to existing compounds like NU7441. This research explores potential applications in treating conditions involving DNA damage, particularly within T-lymphocytes and tumor cell lines. Burns collaborates with researchers including Randall R Rainwater, Brendan Frett, Ana Clara P. Azevedo‐Pouly, and Baku Acharya, all affiliated with the University of Arkansas for Medical Sciences. Her scholarly work to date includes one publication and has garnered one citation, with an h-index of 1.
Metrics
- h-index: 1
- Publications: 1
- Citations: 2
Selected Publications
-
Discovery of the DNA-PKcs inhibitor DA-143 which exhibits enhanced solubility relative to NU7441 (2024)
Collaboration Network
Top Collaborators
- Discovery of the DNA-PKcs inhibitor DA-143 which exhibits enhanced solubility relative to NU7441
- Discovery of the DNA-PKcs inhibitor DA-143 which exhibits enhanced solubility relative to NU7441
- Discovery of the DNA-PKcs inhibitor DA-143 which exhibits enhanced solubility relative to NU7441
- Discovery of the DNA-PKcs inhibitor DA-143 which exhibits enhanced solubility relative to NU7441
- Discovery of the DNA-PKcs inhibitor DA-143 which exhibits enhanced solubility relative to NU7441
- Discovery of the DNA-PKcs inhibitor DA-143 which exhibits enhanced solubility relative to NU7441
- Discovery of the DNA-PKcs inhibitor DA-143 which exhibits enhanced solubility relative to NU7441
- Discovery of the DNA-PKcs inhibitor DA-143 which exhibits enhanced solubility relative to NU7441
- Discovery of the DNA-PKcs inhibitor DA-143 which exhibits enhanced solubility relative to NU7441
- Discovery of the DNA-PKcs inhibitor DA-143 which exhibits enhanced solubility relative to NU7441
- Discovery of the DNA-PKcs inhibitor DA-143 which exhibits enhanced solubility relative to NU7441
Similar Researchers
Based on overlapping research topics